AB BioTechnologies, Inc. is a contract service provider located in Bloomington, Indiana with a small dedicated staff of full-time employees with an analytical contractor.  The lab is full of various types of instrumentation and analytical equipment for the formulation and process development of injectable drug products, diagnostics, and tissue products.  They are currently doing research and development services for clients, and are not approved by the Food and Drug Administration (FDA) at this time to manufacture products that will be administered to humans or animals.  The eventual goal, as part of the next phase of expansion, is to have facilities, staff, and licenses from the FDA to manufacture injectable drugs for human and animal Toxicology and Phase I Clinical Trials.

AB BioTechnologies was founded in February 2008 by J. Jeff Schwegman, Ph.D.  AB BioTechnologies was started in the back bedroom of his home at the time, and he operated the company simply as a teaching and consulting firm.  In early 2010 the first small laboratory was opened, and the company quickly grew over the next few years tripling profits each year, adding new lab equipment, and going through two lab expansions to keep up with the demand for their services.

The company is in the process of an expansion which will include a new building, new employees, and new equipment.  The expansion will allow the company to manufacture and test injectable drug products that will be used in early phase Clinical Trials on humans and animals.  The company plans to employ a staff of approximately 25 people including scientists, operators, and support staff.